Osteoporosis : assessment, prevalence and current treatment options [E-Book]

Includes bibliography and index.

Description based on print version record.

OSTEOPOROSIS: ASSESSMENT, PREVALENCE AND CURRENT TREATMENT OPTIONS; OSTEOPOROSIS: ASSESSMENT, PREVALENCE AND CURRENT TREATMENT OPTIONS; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: HDACS AND OSTEOPOROSIS; ABSTRACT; INTRODUCTION; HDACS AND BONE FORMATION; Class I HDACs and Bone Formation; HDAC1/HDAC2; HDAC3/HDAC8; Class II HDACs and Bone Formation; HDAC4/HDAC5; HDAC6/HDAC7; Class III HDACs and Bone Formation; HDACS AND BONE RESORPTION; Class I HDACs and Bone Resorption; HDAC2/HDAC3; Class II HDACs and Bone Resorption; HDAC6/HDAC7; HDAC9

Class III HDACs and Bone ResorptionCONCLUSION; REFERENCES; BIOGRAPHICAL SKETCH; Chapter 2: MASTOCYTOSIS-INDUCED OSTEOPOROSIS: A RARE CAUSE FOR SECONDARY OSTEOPOROSIS; ABSTRACT; INTRODUCTION; MATERIALS AND METHODS; CONCLUSION; The Influence of Mast Cells on Bone; Mast Cells and Bone Turnover; Clinical Presentation of Mastocytosis-Induced Osteoporosis; Treatment Options; REFERENCES; Chapter 3: OSTEOPOROSIS AND THE STOMATOGNATHIC SYSTEM; ABSTRACT; 1. INTRODUCTION; 2. OSTEOPOROSIS; 3. THE STOMATOGNATHIC SYSTEM-ABOUT THE SYSTEM BONES; Maxilla/Jaw; Mandible; The Temporal-Mandibular Joint

4. THE RELATIONSHIP BETWEEN OSTEOPOROSISAND THE STOMATOGNATHIC SYSTEMBisphosphonates; 5. IMPLANTOLOGY AND OSTEOPOROSIS; Osteoporosis and the Teeth Loss; CONCLUSION; REFERENCES; Chapter 4: OSTEOPOROSIS AND JAWBONES: A DENTAL PERSPECTIVE; ABSTRACT; INTRODUCTION; DENTAL RADIOGRAPHS AS A SCREENING TOOLS FOR OSTEOPOROSIS; OSTEOPOROSIS AND THE ORAL CAVITY; Periodontitis; Dental Implants; Medication-Related Osteonecrosis of the Jaws (MRONJ); CONCLUSION; REFERENCES; BIOGRAPHICAL SKETCH; Chapter 5: DENTAL TREATMENT OF A PATIENT WITH OSTEOPOROSIS; ABSTRACT; 1. INTRODUCTION; 2. BISPHOSPHONATES

3. ADVERSE EFFECTS OF BISPHOSPHONATE INTHE ORAL CAVITY3.1. Stomatitis; 3.2. Osteonecrosis of the Jaws; 3.3. Other Adverse Effects in the Oral Cavity; 4. USE OF BISPHOSPHONATES IN TREATMENT OF OROFACIAL PATHOLOGY; 4.1. Stomatological Treatment of Patients with Osteoporosis; 4.2. General Rules for Stomatological Treatment of the So- Called Risk Patients; 4.2.1. History (Anamnesis); 4.2.2. Laboratory Tests; 4.2.3. Plan of Therapy; 4.2.4. Timing of Dental Interventions; 4.2.5. Local Anesthesia; 4.2.6. Patient-Related Issues; 4.2.7. Restorative Dentistry and Prosthodontics; 4.2.8. Endodontics

4.2.9. Management of Periodontal Diseases4.2.10. Orthodontics; 4.2.11. Oral and Maxillofacial Surgery; 4.2.11.1. Aftercare Instructions for the Patient; 4.2.12. Implant Placement and Maintenance; CONCLUSION; REFERENCES; BIOGRAPHICAL SKETCH; Chapter 6: TREATMENT OF OSTEOPOROTIC FRACTURES: WE NEED MORE THAN FRACTURE CARE; ABSTRACT; THE PUBLIC HEALTH BURDEN OF OSTEOPOROSIS; Pharmacologic Treatment; Bisphosphonates; Denosumab; Strontium Ranelate; Bone Anabolic Agents; Secondary Fracture Prevention; Health Care Delivery Models for Secondary Prevention of Low Trauma Fracture

Master record variable field(s) change: 050, 650